MASSDEVICE ON CALL — Medical device company Medtronic (NYSE:MDT) is looking for a partnership to help push its Alzheimer’s drug pumps to the next level.
Medtronic is looking to make a friend in the pharmaceutical industry to further test its hypothesis that Alzheimer’s drugs may work better if delivered directly to the brain.
"We have proof of concept and we’re looking for partners," Medtronic CNS drug delivery director Lisa Shafer told Bloomberg.
Researchers lose patient clinical research data
The Feinstein Institute for Medical Research notified certain patients participating in a clinical study that a laptop containing research information was stolen from an employees car, potentially exposing personal and health information.
Read more
Covidien’s new catheters arrive worldwide
Medical device company Covidien (NYSE:COV) announced that its Viance Crossing Catheter and Enteer Re-Entry System were on markets worldwide, including in the U.S. and the European Union.
Read more
Harvard Medical school fights $1.5M fine for lost medical data
Harvard Medical School is fighting a $1.5 million fine imposed on one of its teaching hospitals over a data breach that may have exposed data on 3,500 patients.
Read more
Cali officials push Obamacare marketing ploy on television producers
California officials are turning to television shows, including Dr. Oz, Modern Family and others, to develop story lines and and help promote President Barack Obama’s healthcare reform measures.
Read more
